Imprimis Pharmaceuticals

Surgeons from the VA using Dropless--Read the full article on how these surgeons address need for payment for an alternative to drop therapy after Cataract Surgery.

Imprimis has served over 1 million patient eyes with patent-pending Dropless and LessDrops ophthalmic formulations. Read the full article in Eyewire Today!

We're excited to announce our spin-off company, Eton Pharmaceuticals, which is a separately managed and financed entity to develop and commercialize two of our patent-pending sterile injectable drug candidates. Read all about Eton here: http://bit.ly/2tqEQiv $IMMY

We are still so ecstatic about our CEO Mark Baum taking home the 2017 Ernst & Young Entrepreneur of the Year Award for Life Science! We hope that he takes home the National Award in the Fall as well! Hear a part of his awesome acceptance speech here: https://go.ey.com/2s7zGYm $IMMY

Our very own CEO Mark Baum won the Ernst & Young San Diego Entrepreneur of the Year award in Life Science! Join us in congratulating him on a job well done! We can't think of anyone more deserving of this prestigious award. Congrats Mark! https://go.ey.com/2s7zGYm

In the cover focus of Cataract & Refractive Surgery Today, Imprimis CEO Mark Baum discusses the current issues around drug pricing and why the government should rethink low-cost compounded alternatives. Read the full story here: http://bit.ly/2rrTm8G

Our very own CEO Mark Baum has been chosen as a finalist for the Entrepreneur Of The Year 2017 Award in San Diego! Help us in wishing him good luck in winning the award on June 12th! See the details here: http://bit.ly/2pRU5yA

Imprimis CEO Mark Baum had the honor of giving the College of Liberal Arts commencement address at UT Arlington, his alma mater, this past weekend. See his inspiring message to the graduating class of 2017 here: https://youtu.be/u3k0pt3x_ao?t=27m15s

The Imprimis team is staying busy even after the show doors close for the day! Dr. William Wiley spoke about his experience with GoDropless and LessDrops tonight to a group of physicians with our own CEO Mark Baum!

Catch #Droppy at the Los Angeles Convention Center at booth #3038 this weekend and come learn about our new preservative-free Glaucoma Drops, Simple Drops!

Dr. William Wiley is finishing up his in-booth presentation with us on the benefits of using LessDrops in your practice. Come and visit us at booth #3038 to see our next presentation at 1:30pm with Dr. Bret Fisher who will be discussing IV Free, LessDrops, and GoDropless.

Imprimis has partnered with SightLife Surgical to offer Serum Tears in the very near future. Read all about our exciting new partnership via EyeWireToday here: http://bit.ly/2pUjvQ2

Visit us at ASCRS this weekend at booth #3038! You can learn more about our new Simple Drops preservative-free glaucoma formulations, our new FDA-registered 503B outsourcing facility, and more exciting news during our in-booth presentations! Check out the full schedule here: http://bit.ly/2psTNkf